When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

A big rally in defense stocks, deal-fueled gains in banks and a surge in Siemens Energy AG shares were among the main ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Novo Nordisk is planning to open an artificial intelligence (AI) research facility in London, UK, as part of a drive to place the technology at the heart of its drug discovery operations.

Phuket is set to make history on January 22 next year, as the island hosts a dazzling event to mark the first day of legal same-sex marriages in Thailand. Held at Jungceylon shopping mall in Patong, ...

Atalanta kept hold of top spot in Serie A on Saturday after escaping Lazio with a 1-1 draw which kept Inter Milan at bay but ended their club-record league winning streak at 11 matches.

The Greek government presented on Monday its long-awaited national strategy aiming to protect minors from internet addiction and social media overexposure. The National Strategy for the Protection of ...

Eli Lilly and Novo Nordisk are likely to introduce its popular injectable drugs semaglutide and tirzepatide in India in 2025.